Journal of Medical Economics
Volume 27, 2024 - Issue 1
Infectious Diseases
Comparative analysis of tabelecleucel and current treatment in patients with Epstein-Barr virus-positive post-transplant lymphoproliferative disease following hematopoietic cell transplant or solid organ transplant
Arie Barleva Atara Biotherapeutics, Thousand Oaks, CA, USACorrespondence[email protected]
https://orcid.org/0000-0002-2999-7647View further author information
https://orcid.org/0000-0002-2999-7647View further author information, Heiner Zimmermannb Pius-Hospital, University Medicine Oldenburg, Oldenburg, Germanyhttps://orcid.org/0000-0002-4242-275XView further author information
https://orcid.org/0000-0002-4242-275XView further author information, , Aditi Mehtaa Atara Biotherapeutics, Thousand Oaks, CA, USAhttps://orcid.org/0009-0003-5419-2079View further author information
https://orcid.org/0009-0003-5419-2079View further author information, , Bérengère Macabeoc Pierre Fabre Group, Boulogne Billancourt, Francehttps://orcid.org/0000-0001-9719-1584View further author information
https://orcid.org/0000-0001-9719-1584View further author information, & M. Alan Brookhartd Duke University, Durham, NC, USAhttps://orcid.org/0000-0003-1572-0564View further author information
https://orcid.org/0000-0003-1572-0564View further author information show all